Paliperidone Palmitate-induced Urinary Incontinence: A Case Report.

about

Paliperidone Palmitate-induced Urinary Incontinence: A Case Report.

Item

http://www.wikidata.org/entity/Q43063836

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Paliperidone Palmitate-induced Urinary Incontinence: A Case Report.

@en

Paliperidone Palmitate-induced Urinary Incontinence: A Case Report.

@nl

type

Item

label

Paliperidone Palmitate-induced Urinary Incontinence: A Case Report.

@en

Paliperidone Palmitate-induced Urinary Incontinence: A Case Report.

@nl

prefLabel

Paliperidone Palmitate-induced Urinary Incontinence: A Case Report.

@en

Paliperidone Palmitate-induced Urinary Incontinence: A Case Report.

@nl

P1476

Paliperidone Palmitate-induced Urinary Incontinence: A Case Report.

@en

P2093

Ali Çayköylü

http://www.w3.org/2001/XMLSchema#string

Elvan Özalp

http://www.w3.org/2001/XMLSchema#string

Ersin Hatice Karslıoǧlu

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of two atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anesthetized rats

Paliperidone palmitate for schizophrenia

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial

Once-monthly paliperidone injection for the treatment of schizophrenia

A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia.

Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.

Paliperidone: the evidence of its therapeutic value in schizophrenia.

A controlled, evidence-based trial of paliperidone palmitate, a long-acting injectable antipsychotic, in schizophrenia.

A Post-hoc comparison of paliperidone palmitate to oral risperidone during initiation of long-acting risperidone injection in patients with acute schizophrenia

P304

96-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.9758/CPN.2016.14.1.96

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

291425622

http://www.w3.org/2001/XMLSchema#string

P698

26792046

http://www.w3.org/2001/XMLSchema#string

P932

4730936

http://www.w3.org/2001/XMLSchema#string